Balversa User Reviews & Ratings
Balversa has an average rating of 10.0 out of 10 from a total of 1 reviews on Drugs.com. 100% of reviewers reported a positive experience, while 0% reported a negative experience.
See also:
Reviews may be edited to correct grammar/spelling or remove inappropriate content. Reviews appearing to come from parties with a vested interest are not published. This information is not intended to endorse any medication and should not replace the expertise and judgment of healthcare professionals.
More about Balversa (erdafitinib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Imprints, shape & color data
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
"My wife has advanced breast cancer that has spread to multiple parts of her body. The doctor initially gave her a few days to one week to live. We decided to switch to a different doctor who suggested Balversa as the last resort after seeing her genetic mapping with FGFR gene abnormality. Balversa is a targeted therapy with no known cases of similar situations worldwide. Since taking Balversa, her condition has improved, and her health has gone from untreated to a stable and improving state. Unfortunately, the cost of the medication is incredibly high, and we are financially drained. I am hopeful that the company will consider our case a successful one and provide support for the medication. Balversa has caused some side effects in my wife, including nail and skin issues. However, as a life-saving medication, these issues are being tolerated and not considered significant. The medication is straightforward to use, with 8 mg taken orally daily."